Sign in

CIK 0001534969 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

SERA PROGNOSTICS, INC.

Sign in to watch
Ticker
SERA
Exchange
Nasdaq
Industry
Services-Medical Laboratories
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
261911522
Phone
(801) 990-0520
Business address
2749 E. PARLEYS WAY, SUITE 200, SALT LAKE CITY, UT, 84109
Former names
SERA PROGNOSTICS, INC.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$79,563
in 6 filings

Net −$79,563. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-08-08 Lindgardt Zhenya Chief Executive Officer Sale −8,571 $2.54 $22K 832,294
2025-08-08 Kearney Paul Chief Data Officer Sale −6,460 $2.54 $16K 188,940
2025-08-08 Boniface John J. Chief Scientific Officer Sale −7,094 $2.54 $18K 160,888
2025-08-08 Jackson Benjamin General Counsel Sale −6,447 $2.54 $16K 127,751
2025-08-08 Harrison Robert Gardner Chief Information Officer Sale −5,962 $2.54 $15K 108,577
2025-08-05 Mirza Mansoor Raza Director Sale −225 $2.50 $563 58,702
2025-07-07 Mirza Mansoor Raza Director Sale −234 $2.36 $552 58,927
2025-06-23 Anderson Dyaarl Lee Jr. Chief Commercial Officer Grant or award +67,114 67,114
2025-06-23 Anderson Dyaarl Lee Jr. Chief Commercial Officer Grant or award · Stock Option (right to buy) +102,534 102,534
2025-06-10 Jackson Benjamin General Counsel Sale −965 $1.48 $1K 134,198

Page 7 of 7 · 130 trades